Antibody
|
Immunophenotype
|
---|
CIRC tumor
|
Small cell carcinoma
|
---|
Primary tumor
|
Relapsed tumor
|
---|
Epithelial markers
|
CK7
|
+
|
–
|
–
|
CK8
|
+
|
+
|
±
|
CK18
|
+
|
+
|
±(weakly)
|
CAM5.2
|
+
|
+
|
±
|
AE1/AE3
|
+
|
+
|
±
|
EMA
|
+
|
+
|
+
|
34βE12
|
–
|
–
|
–
|
PSA
|
–
|
–
|
–
|
NKX3.1
|
–
|
–
|
–
|
P504S
|
–
|
–
|
–
|
pCEA
|
–
|
–
|
–
|
CK5/6
|
–
|
–
|
–
|
CK20
|
–
|
–
|
–
|
TTF-1
|
–
|
–
|
±(weakly)
|
Napsin A
|
–
|
–
|
–
|
p63
|
–
|
–
|
–
|
p40
|
–
|
–
|
–
|
Neuroendocrine cell markers
|
NSE
|
–
|
–
|
+
|
Chromogranin A
|
–
|
–
|
±
|
Synaptophysin
|
–
|
–
|
+
|
CD56
|
–
|
–
|
+
|
Lymphoid markers
|
CD3
|
–
|
–
|
–
|
CD4
|
–
|
–
|
–
|
CD5
|
–
|
–
|
–
|
CD8
|
–
|
–
|
–
|
CD20
|
–
|
–
|
–
|
CD30 (Ki-1)
|
–
|
–
|
–
|
CD45 (LCA)
|
–
|
–
|
–
|
CD45RO (UCHL-1)
|
–
|
–
|
–
|
CD79a
|
–
|
–
|
–
|
PAX5
|
–
|
–
|
–
|
EBER-1*
|
–
|
–
|
–
|
FRC markers
|
Tenascin-C
|
–
|
–
|
–
|
Prolyl 3-hydroxylase 1
|
–
|
–
|
–
|
l-caldesmon
|
+
|
+
|
–
|
Prolyl 4-hydroxylase 1
|
+
|
+
|
–
|
Lysyl hydroxylase 3
|
+
|
+
|
–
|
Transglutaminase II
|
+
|
+
|
–
|
α-SMA
|
–
|
–
|
–
|
FDC markers
|
CD23
|
–
|
–
|
–
|
D2–40
|
–
|
–
|
–
|
Clusterin
|
–
|
–
|
–
|
CNA.42
|
–
|
–
|
–
|
NGFR, low affinity
|
–
|
–
|
–
|
CD21
|
–
|
–
|
–
|
CD35
|
–
|
–
|
–
|
Histiocytic/dendritic cell markers
|
CD1a
|
–
|
–
|
–
|
CD11c
|
–
|
–
|
–
|
Langerin
|
–
|
–
|
–
|
DC-SIGN
|
–
|
–
|
–
|
DC-LAMP
|
–
|
–
|
–
|
CD83
|
–
|
–
|
–
|
DEC205
|
–
|
–
|
–
|
S-100
|
–
|
–
|
–
|
CD68
|
–
|
–
|
–
|
Fascin
|
+
|
+
|
–
|
Factor XIIIa
|
–
|
–
|
–
|
Others
|
Melan A
|
–
|
–
|
–
|
HMB45
|
–
|
–
|
–
|
Desmin
|
–
|
–
|
–
|
Vimentin
|
+
|
+
|
–
|
CD34
|
–
|
–
|
–
|
CD117
|
–
|
–
|
–
|
ALK
|
–
|
–
|
–
|
EGFR
|
< 10%
|
20%
|
–
|
p53
|
95%
|
80%
|
–
|
Ki-67 (hot spot)
|
> 75%
|
15%
|
< 50%
|
- – negative, ± partially positive, + diffusely positive, PSA Prostate-specific antigen, NGFR Nerve growth factor receptor, FRC Fibroblastic reticular cell, FDC Follicular dendritic cell, EBER-1 (in situ hybridization) Epstein-Barr virus-encoded small RNA-1, ALK Anaplastic lymphoma kinase, EGFR Epidermal growth factor receptor